ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,616.67
1.16%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Neuralstem Inc (CUR)

  7. Neuralstem Inc (CUR) Noticias

CUR

Neuralstem (CUR)

Neuralstem Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CUR
FechaHoraFuenteTítuloSímboloCompañía
19/03/202112:15GlobeNewswire Inc.NeuroRx Announces Dosing of First Patient with ZYESAMI™ in P2/3 Clinical Study for the Treatment of Moderate and Severe COV...NASDAQ:CURNeuralstem Inc
02/09/202007:00PR Newswire (US)Letter from Seneca Biopharma's Executive ChairmanNASDAQ:CURNeuralstem Inc
27/05/202010:00PR Newswire (US)Seneca Biopharma Announces the Closing of its $5 Million Registered Direct OfferingNASDAQ:CURNeuralstem Inc
04/11/201915:18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CURNeuralstem Inc
31/10/201910:00PR Newswire (US)Seneca Biopharma to Begin Trading Under New Ticker Symbol SNCANASDAQ:CURNeuralstem Inc
30/10/201906:00PR Newswire (US)Seneca Biopharma and QYuns Therapeutics Sign Term Sheet for Global Licensing of Novel Monoclonal Antibodies for Treating Auto...NASDAQ:CURNeuralstem Inc
28/10/201922:24PR Newswire (US)Seneca Biopharma to Present at the 7th China Renaissance Healthcare and Life Sciences Leadership SummitNASDAQ:CURNeuralstem Inc
28/10/201908:00PR Newswire (US)Neuralstem Becomes Seneca BiopharmaNASDAQ:CURNeuralstem Inc
11/10/201918:34Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CURNeuralstem Inc
11/10/201918:32Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:CURNeuralstem Inc
11/10/201918:28Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CURNeuralstem Inc
03/10/201908:31PR Newswire (US)Neuralstem Announces Adjustment to Inducement Grant Under Nasdaq Listing Rule 5636(c)(4)NASDAQ:CURNeuralstem Inc
24/09/201906:30PR Newswire (US)Neuralstem Announces Last Subject Enrolled in Phase 2 Clinical Trial Evaluating Human Neural Stem Cells in Chronic Stroke Pat...NASDAQ:CURNeuralstem Inc
14/08/201906:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CURNeuralstem Inc
14/08/201906:30PR Newswire (US)Neuralstem Reports Second Quarter 2019 Fiscal ResultsNASDAQ:CURNeuralstem Inc
09/08/201908:05Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CURNeuralstem Inc
07/08/201906:30PR Newswire (US)Neuralstem Announces Nasdaq Hearings Panel Grants Request For Continued ListingNASDAQ:CURNeuralstem Inc
31/07/201906:30PR Newswire (US)Neuralstem Closes $7.5 Million Underwritten Public OfferingNASDAQ:CURNeuralstem Inc
29/07/201915:47Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:CURNeuralstem Inc
26/07/201905:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CURNeuralstem Inc
25/07/201921:40PR Newswire (US)Neuralstem Announces Pricing of $7.5 Million Underwritten Public OfferingNASDAQ:CURNeuralstem Inc
25/07/201905:05Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:CURNeuralstem Inc
22/07/201905:17Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:CURNeuralstem Inc
18/07/201906:30PR Newswire (US)Neuralstem Appoints Mary Ann Gray, Ph.D., to Board of DirectorsNASDAQ:CURNeuralstem Inc
16/07/201906:30PR Newswire (US)Neuralstem Announces a 1-for-20 Reverse Stock SplitNASDAQ:CURNeuralstem Inc
03/07/201916:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CURNeuralstem Inc
01/07/201915:30PR Newswire (US)Neuralstem Announces Publication of Results from Phase 1 Clinical Trial Evaluating Human Neural Stem Cells in Chronic Stroke ...NASDAQ:CURNeuralstem Inc
21/06/201916:14Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:CURNeuralstem Inc
16/05/201906:07PR Newswire (US)Neuralstem Announces Issuance of New Patent Covering Broad Therapeutic Use of Neural Stem CellsNASDAQ:CURNeuralstem Inc
14/05/201915:30PR Newswire (US)Neuralstem Reports First Quarter 2019 Fiscal ResultsNASDAQ:CURNeuralstem Inc
 Showing the most relevant articles for your search:NASDAQ:CUR

Su Consulta Reciente

FX
EURMXN
Euro vs MXN
CCOM
SILVER
SILVER
NYSE
VZ
Verizon Communications
USI
USTECH100
US Tech 100
PM
XAUUSD
Gold vs US Dollar
CCOM
US500
US 500
AMEX
XLV
Health Care Select Sector
NASDAQ
GOOGL
Alphabet
COIN
SOLUSD
Solana
CCOM
OILBRENT
Brent Oil
NASDAQ
AMZN
Amazon.com
COIN
BTCUSD
Bitcoin
SPI
SP500
S&P 500
NYSE
NKE
Nike
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados